Thalamic Magnetic Susceptibility (χ) Alterations in Neurodegenerative Diseases: A Systematic Review and Meta-Analysis of Quantitative Susceptibility Mapping Studies.

Melika Arab Bafrani, Farzad Fatehi, Sadegh Ghaderi, Sana Mohammadi, Amir Mahmoud Ahmadzadeh, Kimia Darmiani, Nahid Jashirenezhad, Maryam Helfi, Sanaz Alibabaei, Sareh Azadi, Sahar Heidary

Journal: Journal of magnetic resonance imaging : JMRI 2025;62(1):271-294

PMID: 39832811

Abstract

BACKGROUND

Quantitative Susceptibility Mapping (QSM) provides a non-invasive post-processing method to investigate alterations in magnetic susceptibility (χ), reflecting iron content within brain regions implicated in neurodegenerative diseases (NDDs).

PURPOSE

To investigate alterations in thalamic χ in patients with NDDs using QSM.

STUDY TYPE

Systematic review and meta-analysis.

POPULATION

A total of 696 patients with NDDs and 760 healthy controls (HCs) were included in 27 studies.

FIELD STRENGTH/SEQUENCE

Three-dimensional multi-echo gradient echo sequence for QSM at mostly 3 Tesla.

ASSESSMENT

Studies reporting QSM values in the thalamus of patients with NDDs were included. Following PRISMA 2020, we searched the four major databases including PubMed, Scopus, Web of Science, and Embase for peer-reviewed studies published until October 2024.

STATISTICAL TESTS

Meta-analysis was conducted using a random-effects model to calculate the standardized mean difference (SMD) between patients and HCs.

RESULTS

The pooled SMD indicated a significant increase in thalamic χ in NDDs compared to HCs (SMD = 0.42, 95% CI: 0.05-0.79; k = 27). Notably, amyotrophic lateral sclerosis patients showed a significant increase in thalamic χ (1.09, 95% CI: 0.65-1.53, k = 2) compared to HCs. Subgroup analyses revealed significant χ alterations in younger patients (mean age ≤ 62 years; 0.56, 95% CI: 0.10-1.02, k = 11) and studies using greater coil channels (coil channels > 16; 0.64, 95% CI: 0.28-1.00, k = 9). Publication bias was not detected and quality assessment indicated that studies with a lower risk of bias presented more reliable findings (0.75, 95% CI: 0.32-1.18, k = 9). Disease type was the primary driver of heterogeneity, while other factors, such as coil type and geographic location, also contributed to variability.

DATA CONCLUSION

Our findings support the potential of QSM for investigating thalamic involvement in NDDs. Future research should focus on disease-specific patterns, thalamic-specific nucleus analysis, and temporal evolution.

PLAIN LANGUAGE SUMMARY

Our research investigated changes in iron levels within the thalamus, a brain region crucial for motor and cognitive functions, in patients with various neurodegenerative diseases (NDDs). The study utilized a specific magnetic resonance imaging technique called Quantitative Susceptibility Mapping (QSM) to measure iron content. It identified a significant increase in thalamic iron levels in NDD patients compared to healthy individuals. This increase was particularly prominent in patients with Amyotrophic Lateral Sclerosis, younger individuals, and studies employing advanced imaging equipment.

LEVEL OF EVIDENCE

2 TECHNICAL EFFICACY: Stage 2.

© 2025 International Society for Magnetic Resonance in Medicine.

Address: Neuromuscular Research Center, Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.; Neuromuscular Research Center, Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Department of Radiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.; Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran.; The Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, Iran.; Department of Medical Physics, School of Medicine, Mashhad University of Medical Science, Mashhad, Iran.; Department of Medical Physics, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.; Department of Biotechnology, Faculty of Allied Medicine, Iran University of Medical Science, Tehran, Iran.; Health Institute, Medical Physics Department, Yeditepe University, Istanbul, Turkey.; Neuromuscular Research Center, Department of Neurology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.; Neurology Department, University Hospitals of Leicester NHS Trust, Leicester, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.